DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.94, $0.30 better than the analyst estimate of $0.64. Revenue for the quarter came in at $500.9 million versus the consensus estimate of $476.75 million.

GUIDANCE:

DexCom sees FY2020 revenue of ~$1.9 billion, versus the consensus of $1.87 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.